Bulletin of the World Health Organization

The incremental cost of switching from Option B to Option B+ for the prevention of mother-to-child transmission of HIV

Lisa O’Brien, Nathan Shaffer, Nalinee Sangrujee & Taiwo O Abimbola

Volume 92, Number 3, March 2014, 162-170

Table 2. Time spent per woman in Option Ba or Option B+b over 5 years postpartum

Breastfeeding status and duration CD4+ count 350–500 cells/µl
CD4+ count > 500 cells/µl
Months spent in care (pre-ART) First 12 months on ART Remaining months on ART Months spent in care (pre-ART) First 12 months on ART Remaining months on ART
Breastfeeding
12 months 23c 12 13 48 0 0
18 months 23c 12 7 42 0 0
24 months 23c 12 1 36 0 0
No breastfeeding 17 12 31 60 0 0

ART, antiretroviral therapy.

a Option B comprises a maternal triple antiretroviral (ARV) regimen, typically consisting of the recommended first-line ART, during pregnancy and throughout breastfeeding, in combination with 6 weeks of daily nevirapine for the infant, regardless of infant feeding method.

b Option B+ comprises a triple ARV regimen initiated during pregnancy and continued for life.

c Includes duration of breastfeeding.